PL369268A1 - Stabilna kompozycja farmaceutyczna prawastatyny - Google Patents

Stabilna kompozycja farmaceutyczna prawastatyny

Info

Publication number: PL369268A1
Authority: PL; Poland
Prior art keywords: pravastatin; pharmaceutical composition; stable pharmaceutical; stable; composition
Prior art date: 2001-03-27

Application number

PL02369268A

Other languages

English (en)

Inventor

Vishnubhotla Nagaprasad

Rajiv Malik

Original Assignee

Ranbaxy Laboratories Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-27

Filing date

2002-03-22

Publication date

2005-04-18

2002-03-22 Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited

2005-04-18 Publication of PL369268A1 publication Critical patent/PL369268A1/pl

Links

TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 title 1
229960002965 pravastatin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL02369268A 2001-03-27 2002-03-22 Stabilna kompozycja farmaceutyczna prawastatyny PL369268A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IN375DE2001		2001-03-27

Publications (1)

Publication Number	Publication Date
PL369268A1 true PL369268A1 (pl)	2005-04-18

Family

ID=29560486

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02369268A PL369268A1 (pl)	2001-03-27	2002-03-22	Stabilna kompozycja farmaceutyczna prawastatyny

Country Status (17)

Country	Link
US (1)	US20040157925A1 (pl)
EP (1)	EP1372616A4 (pl)
JP (1)	JP2004527518A (pl)
KR (1)	KR20030096294A (pl)
CN (1)	CN1240377C (pl)
BR (1)	BR0208504A (pl)
CA (1)	CA2442280A1 (pl)
CZ (1)	CZ20032828A3 (pl)
EE (1)	EE200300468A (pl)
HU (1)	HUP0401234A2 (pl)
MX (1)	MXPA03008837A (pl)
NZ (1)	NZ528543A (pl)
PL (1)	PL369268A1 (pl)
RU (1)	RU2003131338A (pl)
SK (1)	SK13022003A3 (pl)
WO (1)	WO2002076376A2 (pl)
ZA (1)	ZA200308256B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003055217A (ja) *	2001-08-10	2003-02-26	Taiyo Yakuhin Kogyo Kk	医薬組成物
CA2465693A1 (en) *	2003-06-12	2004-12-12	Warner-Lambert Company Llc	Pharmaceutical compositions of atorvastatin
DK1651194T3 (da) *	2003-08-06	2010-07-26	Galephar M F	Stabile farmaceutiske sammensætninger med kontrolleret frigivelse, hvilke indeholder fenofibrat og pravastatin
WO2006008757A2 (en) *	2004-05-05	2006-01-26	Cadila Healthcare Limited	Stabilized pharmaceutical compositions of pravastatin
US20100217032A1 (en) *	2006-12-13	2010-08-26	Paul Klaassen	Process for preparing pravastatin
CA2691956A1 (en) *	2007-06-25	2008-12-31	Pharmathen S.A.	Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
GB0713707D0 (en) *	2007-07-13	2007-08-22	Generics Uk Ltd	Stable compositions
JPWO2011049122A1 (ja) *	2009-10-21	2013-03-14	第一三共株式会社	プラバスタチンナトリウム口腔内速崩壊錠及びその製造方法
JP5988963B2 (ja)	2011-04-12	2016-09-07	沢井製薬株式会社	ピタバスタチン含有製剤及びその製造方法
WO2013139695A1 (en)	2012-03-22	2013-09-26	Novo Nordisk A/S	Compositions comprising a delivery agent and preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK149080C (da) *	1980-06-06	1986-07-28	Sankyo Co	Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
US5030447A (en) *	1988-03-31	1991-07-09	E. R. Squibb & Sons, Inc.	Pharmaceutical compositions having good stability
US5225202A (en) *	1991-09-30	1993-07-06	E. R. Squibb & Sons, Inc.	Enteric coated pharmaceutical compositions
IL118778A (en) *	1995-07-03	1999-07-14	Sankyo Co	Pharmaceutical compositions for the treatment of arteriosclerosis and xanthoma containing an hmg-coa reductase inhibitor
US6235311B1 (en) *	1998-03-18	2001-05-22	Bristol-Myers Squibb Company	Pharmaceutical composition containing a combination of a statin and aspirin and method
SI20109A (sl) *	1998-12-16	2000-06-30	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Stabilna farmacevtska formulacija

2002
- 2002-03-22 NZ NZ528543A patent/NZ528543A/en unknown
- 2002-03-22 MX MXPA03008837A patent/MXPA03008837A/es not_active Application Discontinuation
- 2002-03-22 WO PCT/IB2002/000882 patent/WO2002076376A2/en not_active Ceased
- 2002-03-22 CZ CZ20032828A patent/CZ20032828A3/cs unknown
- 2002-03-22 EP EP02716958A patent/EP1372616A4/en not_active Withdrawn
- 2002-03-22 EE EEP200300468A patent/EE200300468A/xx unknown
- 2002-03-22 SK SK1302-2003A patent/SK13022003A3/sk unknown
- 2002-03-22 CN CNB028093542A patent/CN1240377C/zh not_active Expired - Fee Related
- 2002-03-22 CA CA002442280A patent/CA2442280A1/en not_active Abandoned
- 2002-03-22 HU HU0401234A patent/HUP0401234A2/hu unknown
- 2002-03-22 JP JP2002574892A patent/JP2004527518A/ja not_active Withdrawn
- 2002-03-22 KR KR10-2003-7012675A patent/KR20030096294A/ko not_active Withdrawn
- 2002-03-22 BR BR0208504-6A patent/BR0208504A/pt not_active IP Right Cessation
- 2002-03-22 PL PL02369268A patent/PL369268A1/pl not_active Application Discontinuation
- 2002-03-22 RU RU2003131338/15A patent/RU2003131338A/ru not_active Application Discontinuation
2003
- 2003-10-23 ZA ZA200308256A patent/ZA200308256B/en unknown
2004
- 2004-04-12 US US10/473,208 patent/US20040157925A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1240377C (zh)	2006-02-08
ZA200308256B (en)	2004-08-12
EP1372616A2 (en)	2004-01-02
KR20030096294A (ko)	2003-12-24
BR0208504A (pt)	2004-03-09
HUP0401234A2 (hu)	2004-11-29
CA2442280A1 (en)	2002-10-03
SK13022003A3 (sk)	2004-03-02
WO2002076376A3 (en)	2003-01-09
MXPA03008837A (es)	2004-05-05
CZ20032828A3 (en)	2004-07-14
RU2003131338A (ru)	2005-02-10
JP2004527518A (ja)	2004-09-09
US20040157925A1 (en)	2004-08-12
WO2002076376A2 (en)	2002-10-03
EE200300468A (et)	2004-02-16
EP1372616A4 (en)	2004-06-23
NZ528543A (en)	2005-07-29
CN1518443A (zh)	2004-08-04

Legal Events

Date	Code	Title	Description
2009-07-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
SI1390023T1 (sl)	2008-10-31	Farmacevtske soli spojin 1-fenil-3-dimetilamino-propana
EP1450824A4 (en)	2005-09-28	PHARMACEUTICAL COMPOSITION
EP1407785A4 (en)	2009-12-02	MEDICAL COMPOSITIONS
HUP0401333A3 (en)	2004-11-29	Spiropyrazole compounds and pharmaceutical compositions containing them
GB0111597D0 (en)	2001-07-04	Pharmaceutical compositions
HUP0303163A3 (en)	2008-03-28	Tramadol-based pharmaceutical composition
GB0117057D0 (en)	2001-09-05	Pharmaceutical composition
GB0101227D0 (en)	2001-02-28	Pharmaceutical compounds
GB0129117D0 (en)	2002-01-23	Pharmaceutical composition
GB0101225D0 (en)	2001-02-28	Pharmaceutical compounds
PL369268A1 (pl)	2005-04-18	Stabilna kompozycja farmaceutyczna prawastatyny
GB0104752D0 (en)	2001-04-18	Pharmaceutical compositions
EP1404303A4 (en)	2006-03-15	STABLE PHARMACEUTICAL COMPOSITIONS BASED ON PRAVASTATIN
GB0116107D0 (en)	2001-08-22	Pharmaceutical composition
GB0127805D0 (en)	2002-01-09	Pharmaceutical composition
PL370037A1 (pl)	2005-05-16	Kompozycja farmaceutyczna
HUP0302531A3 (en)	2007-06-28	Pharmaceutical compositions containing citalopram
GB2382302B (en)	2006-08-02	Pharmaceutical compositions
HK1061653A (en)	2004-09-30	A stable pharmaceutical composition of pravastatin
IL157411A0 (en)	2004-03-28	Pharmaceutical composition
GB0126732D0 (en)	2002-01-02	Pharmaceutical compositions
HU0103049D0 (en)	2001-10-28	Pharmaceutical composition
GB0125061D0 (en)	2001-12-12	Pharmaceutical composition
IL161956A0 (en)	2005-11-20	Pharmaceutical compositions containing 5-bisoprolol
AU2002323900A1 (en)	2003-03-03	Sustained-release medicinal compositions